GlassScriptPhysician profile
Joshua Brown
NPI 1548634389
$928.51
in general payments reported to CMS, 2019-2025
18 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.47 · 2024: $517 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.29 | 2024-2025 | Jardiance |
| Novo Nordisk INC | $178.84 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $100.83 | 2024 | |
| Amgen INC. | $85.22 | 2024-2025 | Otezla, Repatha, Repatha |
| Sumitomo Pharma America, INC. | $44.36 | 2024 | Gemtesa |
| Glaxosmithkline, LLC. | $39.71 | 2024-2025 | Shingrix, Trelegy Ellipta |
| Corcept Therapeutics | $36.72 | 2024 | Korlym |
| Lilly USA, LLC | $33.03 | 2024-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $29.51 | 2025 | Airsupra |
| Sanofi-Aventis U.S. LLC | $21.47 | 2021 | |
| Abbott Laboratories | $20.63 | 2024 | Freestyle Libre |
| Globus Medical, INC. | $19.92 | 2025 | Omnia |
| Nevro Corp. | $19.08 | 2024 | Senza |
| Aimmune Therapeutics, INC. | $18.86 | 2024 | |
| Exact Sciences Corporation | $17.79 | 2025 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $15.73 | 2024 | Tymlos |
| Pfizer INC. | $15.07 | 2024 | |
| Merck Sharp & Dohme LLC | $13.45 | 2024 | Capvaxive, Gardasil 9, Gardasil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.